The higher barrier of darunavir and tipranavir resistance for HIV-1 protease

► Darunavir and tipranavir show higher drug-resistance barrier for HIV-1 protease. ► Darunavir preserves its potency by forming protease backbone hydrogen bonds. ► Tipranavir maintains its potency by stabilizing the protease flaps.